Carl Culicchia - Profile and Investment Details

Investor Profile

Carl Culicchia is a Venture Capital, Private Equity Firm based in Milton, Massachusetts, United States with a diverse investment portfolio that includes companies such as Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide, myOrthos, CSA Medical, Avitide, Sutro Biopharma, CardioFocus, TopiVert, Aligned TeleHealth, LOQUS23 THERAPEUTICS, CytoMed Therapeutics, Bicycle Therapeutics, Jet Health, Sopris Health, Centauri Health Solutions, PanOptica, Halscion, Inc., Urgent Team Holdings, Inc., Arsanis, Atopix Therapeutics, Bardy Diagnostics, EBT Medical, Cibiem, Inc., CardioKinetix, Amwell, Avrobio, NKT Therapeutics, Pionyr Immunotherapeutics, Healthify, Zarodex Therapeutics, Misonix, Sitryx Therapeutics, KalVista Pharmaceuticals, Good Start Genetics, Centauri Health Solutions, Inc, Exalt Health, Aerocare Holdings, Remita Health, CerevanceKarus Therapeutics, Ribometrix, Transposon Therapeutics, Spinal Kinetics, Catamaran Bio, Thesan Pharmaceuticals, Autifony Therapeutics, ReShape Lifesciences, Leiter's, Artios Pharma, Endotronix, Maestro Health, EBR Systems, ValenTx, AllianceCare, Xilio Therapeutics, HealthPRO Heritage, Evidation Health, SUN Behavioral Health, Caraway Therapeutics, Soffio Medical, Zerigo Health, VHSquared, AqueSys, Doctors of Physical Therapy, AcuFocus, Cellinta, Schweiger Dermatology, Deciphera Pharmaceuticals, Delenex Therapeutics, . Over time, Carl Culicchia has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Carl Culicchia is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Investment Management, Life Science, Portfolio Management, Information Services, Social Enterprise, Analytics, Business Development, Finance, Biotechnology, Entrepreneurship, Genomics, Real Estate Development, Clinical Trials, Digital Transformation, Human Capital, Mergers and Acquisitions, Health Diagnostics, Social Impact, Developer Tools, Renewable Energy, Medical, Big Data, B2B, Real Estate, Therapeutics, Financial Advisory, Pharmaceuticals, Risk Management, Acquisitions may find it worthwhile to explore potential connections with Carl Culicchia, as their portfolio suggests a familiarity and interest in this area.

Understanding Carl Culicchia’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.